Preferences for long-acting treatment among people with HIV: a discrete choice experiment
Our results indicate that treatment choice is primarily driven by the mode of administration, with tablets being the most preferred option. This is followed by dosing frequency and risk of viral resistance. These findings offer important insights for optimizing treatment approaches and advancing person-centered care strategies.
Authors
- Suzanne E. Geerlings (ORCID: https://orcid.org/0000-0002-8518-3576)
- Pythia T. Nieuwkerk (ORCID: https://orcid.org/0000-0002-2616-1414)
- Marc van der Valk (ORCID: https://orcid.org/0000-0002-8290-6425)
- Jeannine F. Nellen (ORCID: https://orcid.org/0000-0001-8176-8027)
- Bregtje A. Lemkes
- Kyra F. Mendes de Leon
Institutions
- Netherlands Center for Occupational Diseases (NL)
- Office of Infectious Diseases (US)
- Infectious Diseases Institute (UG)
- Stichting HIV Monitoring (NL)
- Public Health Service of Amsterdam (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- AIDS
- Published
- 2025-07-30
- DOI
- https://doi.org/10.1097/qad.0000000000004314
- Citations
- 1
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 1.40